IndiaTickerLatest filing: Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
ObservedCompany dossier
Solara Active Pharma Sciences
NSE:SOLARA · ISIN INE624Z01016
- Close
- ₹506.2 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Solara Active Pharma Sciences
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹300.3 Cr · PAT ₹8.1 Cr.
Exchange XBRLLatest ownership: promoter group 41.93% and public 58.07% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE · conference call
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Solara Active Pharma Sciences Limited
NSE · conference call
Observed
Source filing Copy of Newspaper Publication - Solara Active Pharma Sciences Limited
NSE · financial results
Observed
Source filing Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · financial results
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹300.3 Cr
- Profit after tax
- ₹8.1 Cr
- EPS
- ₹2.03
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 41.93%
- Public
- 58.07%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL